Trials / Sponsors / Cangene Corporation
Cangene Corporation
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Study of Recombinant Factor IX Product, IB1001, in Previously Treated Subjects With Hemophilia B Hemophilia B | Phase 3 | 2014-03-01 |
| Completed | Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients Hepatitis B, Liver Transplantation | Phase 4 | 2008-02-01 |
| Approved For Marketing | Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infec Varicella | — | 2006-02-01 |